The Journal of Pain
Volume 11, Issue 3 , Pages 264-272 , March 2010

Pharmacological Treatment of Neuropathic Facial Pain in the Dutch General Population

  • Joseph S.H.A. Koopman

      Affiliations

    • Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
    • Corresponding Author InformationAddress reprint requests to Dr. Joseph S.H.A. Koopman, Dept. of Medical Informatics, Room EE 21.55, Erasmus University Medical Center, P.O. BOX 2040, 3000 CA Rotterdam, The Netherlands.
    • ,
  • Frank. J. Huygen

      Affiliations

    • Department of Pain Treatment, Erasmus University Medical Center, Rotterdam, The Netherlands
    • ,
  • Jeanne P. Dieleman

      Affiliations

    • Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
    • ,
  • Marissa de Mos

      Affiliations

    • Department of Anesthesiology, Erasmus University Medical Center, Rotterdam, The Netherlands
    • ,
  • Miriam C.J.M. Sturkenboom

      Affiliations

    • Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
    • Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands

Received 20 April 2009 ,Revised 30 June 2009 ,Accepted 22 July 2009.

References 

  1. Anonymous . ATC and DDD values. Geneva: World Health Organization; 1996;
  2. Anonymous: Detailed description of pain syndromes. Available at: https://www.iasp-pain.org/AM/Template.cfm?section=Classification_of_Chronic_Pain1&template=/MembersOnly.cfm&ContentID=2786. Accessed April 24, 2008
  3. Attal N, Cruccu G, Haanpaa M, Hansson P, Jensen TS, Nurmikko T, et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol. 2006;13:1153–1169
  4. Bowsher D. Trigeminal neuralgia: An anatomically oriented review. Clin Anat. 1997;10:409–415
  5. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10:287–333
  6. CVZ: Farmacotherapeutisch Kompas. Available at: http://www.fk.cvz.nl/ Accessed June 25, 2008
  7. de Lusignan S. Codes, classifications, terminologies and nomenclatures: Definition, development and application in practice. Inform Prim Care. 2005;13:65–70
  8. De Simone R, Ranieri A, Bilo L, Fiorillo C, Bonavita V. Cranial neuralgias: From physiopathology to pharmacological treatment. Neurol Sci 29. 2008;(Suppl 1):S69–S78
  9. Dieleman JP, Kerklaan J, Huygen FJ, Bouma PA, Sturkenboom MC. Incidence rates and treatment of neuropathic pain conditions in the general population. Pain. 2008;137:681–688
  10. Fischbach F, Lehmann TN, Ricke J, Bruhn H. Vascular compression in glossopharyngeal neuralgia: Demonstration by high-resolution MRI at 3 tesla. Neuroradiology. 2003;45:810–811
  11. Hall GC, Carroll D, Parry D, McQuay HJ. Epidemiology and treatment of neuropathic pain: The UK primary care perspective. Pain. 2006;122:156–162
  12. Hall GC, Carroll D, McQuay HJ. Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002-2005. BMC Fam Pract. 2008;9:26
  13. Katusic S, Beard CM, Bergstealh E, Kurland LT. Incidence and clinical features of trigeminal neuralgia, Rochester Minnesota,1945-1984. Ann Neurol. 1990;27:89–95
  14. Katusic S, Williams DB, Beard CM, Bergstralh E, Kurland LT. Incidence and clinical features of glossopharyngeal neuralgia, Rochester, Minnesota, 945-1984. Neuroepidemiology. 1991;10:266–275
  15. Koopman JS, Dieleman JP, Huygen FJ, de Mos M, Martin CG, Sturkenboom MC. Incidence of facial pain in the general population. Pain. 2009 Sep 25;[Epublication ahead of print]
  16. Kost RG, Straus SE. Postherpetic neuralgia–pathogenesis, treatment, and prevention. N Engl J Med. 1996;335:32–42
  17. Love S, Coakham HB. Trigeminal neuralgia: Pathology and pathogenesis. Brain. 2001;124:2347–2360
  18. MEB: Medicines Data Bank. Available at: http://www.cbg-meb.nl/CBG/nl/people/geneesmiddeleninformatiebank/default.htm Accessed July 4, 2008
  19. Post AF, Narayan P, Haid RW. Occipital neuralgia secondary to hypermobile posterior arch of atlas. Case report. J Neurosurg. 2001;94:276–278
  20. Rushton JG, Stevens JC, Miller RH. Glossopharyngeal (vagoglossopharyngeal) neuralgia: A study of 217 cases. Arch Neurol. 1981;38:201–205
  21. Schrijvers A. Health and health care in the Netherlands: a critical self assessment of Dutch experts in medical and health sciences. Utrecht, De Tijdstroom. 1997;
  22. Shimizu S, Oka H, Osawa S, Fukushima Y, Utsuki S, Tanaka R, et al. Can proximity of the occipital artery to the greater occipital nerve act as a cause of idiopathic greater occipital neuralgia? An anatomical and histological evaluation of the artery-nerve relationship. Plast Reconstr Surg. 2007;119:2029–2034discussion 2035-6
  23. Teixeira MJ, de Siqueira SR, Bor-Seng-Shu E. Glossopharyngeal neuralgia: Neurosurgical treatment and differential diagnosis. Acta Neurochir (Wien). 2008;150:471–475discussion 475
  24. Tunsuriyawong S, Puavilai S. Herpes zoster, clinical course and associated diseases: A 5-year retrospective study at Tamathibodi Hospital. J Med Assoc Thai. 2005;88:678–681
  25. Vlug AE, van der Lei J, Mosseveld BM, van Wijk MA, van der Linden PD, Sturkenboom MC, et al. Postmarketing surveillance based on electronic patient records: The IPCI project. Methods Inf Med. 1999;38:339–344

 Supported by an unrestricted grant from DALI for PAIN (Dutch ALliance for Improvement of paincare), a Pfizer initiative.

PII: S1526-5900(09)00633-6

doi: 10.1016/j.jpain.2009.07.001

The Journal of Pain
Volume 11, Issue 3 , Pages 264-272 , March 2010

Article Tools

* Image Usage & Resolution